Last reviewed · How we verify
NCT03143920: HBOTCICrUTI
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
EARLY_PHASE1 trial testing Hyperbaric Oxygen Therapy- in Chronic Interstitial Cystitis in 11 participants. Terminated before completion.
7 July 2022
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 1 November 2017 |
| Primary completion | 7 July 2022 |
| Estimated completion | 7 July 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hyperbaric Oxygen Therapy-
Conditions studied
- Chronic Interstitial Cystitis — all drugs for Chronic Interstitial Cystitis →
- Painful Bladder Syndrome — all drugs for Painful Bladder Syndrome →
- Recurrent Urinary Tract Infection — all drugs for Recurrent Urinary Tract Infection →
Sponsor
University of California, San Diego
Who can join
Adults 35 to 70, female only, with Chronic Interstitial Cystitis or Painful Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pilot study to determine feasibility for treating patients with two chronic inflammatory conditions of the urinary bladder: chronic interstitial cystitis and recurrent urinary tract infections using a standardized hyperbaric oxygen treatment plan. Presently there are no good treatments for these conditions and hyperbaric oxygen may be a safe and readily accessible therapy as it has proven successful an another type of chronic inflammatory condition of the urinary bladder known as "radiation cystitis". The study will determine if patients will consider this an acceptable treatment for their conditions and that it is well tolerated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03143920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Interstitial Cystitis
Currently open trials in the same condition.
- NCT06299683 — Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment · NA · recruiting
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03143920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 11 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03143920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing